ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

IDYA IDEAYA Biosciences Inc

38.11
-0.82 (-2.11%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 524,927
Bid Price 37.43
Ask Price 41.13
News -
Day High 38.86

Low
20.90

52 Week Range

High
47.735

Day Low 37.82
Share Name Share Symbol Market Stock Type
IDEAYA Biosciences Inc IDYA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.82 -2.11% 38.11 19:00:00
Open Price Low Price High Price Close Price Previous Close
38.41 37.82 38.86 38.11 38.93
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
10,613 524,927 US$ 38.35 US$ 20,132,708 - 20.90 - 47.735
Last Trade Type Quantity Price Currency
15:20:00 94 US$ 38.11 USD

IDEAYA Biosciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.84B 74.56M - 23.39M -112.96M -1.52 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

IDEAYA Biosciences News

Date Time Source News Article
6/03/202405:05Edgar (US Regulatory)Form 8-K - Current report
6/03/202405:00PR Newswire (US)IDEAYA Announces Results for Darovasertib Phase 2 IST in..
5/31/202415:54Edgar (US Regulatory)Form 8-K - Current report
5/31/202415:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/31/202415:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/31/202405:00PR Newswire (US)IDEAYA Biosciences Announces Inducement Grants under Nasdaq..
5/29/202416:02Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
5/29/202405:00PR Newswire (US)IDEAYA Biosciences to Participate in Upcoming June 2024..
5/28/202405:00PR Newswire (US)IDEAYA Biosciences Appoints Daniel A. Simon as Chief..
5/23/202420:21PR Newswire (US)/C O R R E C T I O N -- IDEAYA Biosciences, Inc./
5/23/202416:05PR Newswire (US)IDEAYA Biosciences Announces Abstract Summary Results of..
5/07/202405:04Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No IDYA Message Board. Create One! See More Posts on IDYA Message Board See More Message Board Posts

Historical IDYA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week39.3940.6536.8538.47770,007-1.28-3.25%
1 Month40.8942.2035.5738.581,002,056-2.78-6.80%
3 Months45.3245.3235.5740.02731,441-7.21-15.91%
6 Months33.0647.73532.5640.56868,8935.0515.28%
1 Year25.0547.73520.9034.71769,14913.0652.14%
3 Years21.0147.7358.1425.66531,39117.1081.39%
5 Years10.6247.7352.9524.01369,83227.49258.85%

IDEAYA Biosciences Description

IDEAYA Biosciences Inc an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically-defined cancers having GNAQ or GNA11 gene mutations.